Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CO2Meter is a private U.S.-based designer and manufacturer of gas detection, monitoring, and analytical devices focused primarily on carbon dioxide, oxygen, and multi-gas safety applications. The company sells fixed and portable detectors, alarms, sensors, data loggers, and related services for customers in industrial safety, indoor air quality, hospitality, beverage, agriculture, scientific research, medical, and laboratory markets. Founded in 2006, CO2Meter has expanded from carbon dioxide monitoring into broader multi-gas and oxygen sensing offerings, including through its 2022 acquisition of GasLab.com. Its business appears to be centered on commercial hardware, sensor integration, compliance-oriented safety solutions, and installation/calibration support rather than therapeutics or drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CO2Meter.